US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Weight Loss Drugs

1,263.99

-26.8967-2.08%

Number of Gainers:- -

Number of Losers:7

Number of Flat:- -

PE:- -

High:1,282.13

Open:1,281.84

Low:1,261.60

Close:1,290.88

Volume:35.29M

Turnover:3.29B

Market Cap:1.32T

Float Cap:1.27T

Loading ...

Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market

Eli Lilly Stock (LLY) Falls as Canada Approves Generic Weight-Loss Drugs

MDB Capital report says retatrutide hits 28.7% weight loss, shifts obesity drug race to IP

3SBio publishes 2025 annual report

RPT-BREAKINGVIEWS-Quantum computing awaits its ChatGPT moment

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer price target raised to $27 from $26 at Citi

Pfizer says Phase 3 MagnetisMM-5 trial meets primary endpoint for ELREXFIO in myeloma

Pfizer - Elrexfio Demonstrates Superior Progression-Free Survival Versus Standard-of-Care Dpd

THOMSON REUTERS

Pfizer - No New Safety Signals Identified for Elrexfio in Magnetismm-5 Trial

THOMSON REUTERS

Pfizer - Magnetismm-5 Trial Meets Primary Endpoint at Interim Analysis

THOMSON REUTERS

Pfizer’s Elrexfio Significantly Improves Progression-Free Survival for Double-Class Exposed Patients With Relapsed or Refractory Multiple Myeloma

THOMSON REUTERS

Pfizer - Magnetismm-5 Trial Ongoing to Assess Overall Survival

THOMSON REUTERS

Eli Lilly investors look for insight into Foundayo launch data, Reuters says

PREVIEW-Eli Lilly investors are eager for Foundayo insight after early launch data

Update: Amgen's Tavneos Proposed to be Withdrawn by US FDA's Center for Drug Evaluation and Research

MT Newswires Live

Pfizer : Jefferies Raises Target Price to $35 From $34

THOMSON REUTERS

Health Canada approves first generic version of Novo Nordisk’s Ozempic

Novo Nordisk’s Oral Ozempic And Pediatric Plans Reframe GLP-1 Opportunity

Simply Wall St.

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1263.9877,"timestamp":1777486575884,"preClose":1290.8844,"halted":0,"volume":35292345,"delay":0,"changeRate":-0.020836,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-26.896729,"latestTime":"04-29 14:16:16 EDT","open":1281.8401,"high":1282.1302,"low":1261.6,"amount":3294734595.481139,"amplitude":0.015904,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777492800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":8.44727,"peRate":25.293016,"turnoverRate":0.003299,"increases":0,"decrements":7,"flats":0,"marketCap":1321503253376,"floatMarketCap":1269475362688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1282.1302,"amplitude":0.015904,"preClose":1290.8844,"low":1261.6,"pbRate":"8.44727","latestPrice":1263.9877,"volume":35292345,"delay":0,"open":1281.8401,"prevYearClose":1494.5856,"prevWeekClose":1305.4105,"prevMonthClose":1333.3853,"prevQuarterClose":1333.3853,"fiveDayClose":1332.9296,"twentyDayClose":1333.3853,"sixtyDayClose":1514.1146,"secType":"PLATE","market":"US","turnoverRate":0.003299,"peRate":25.293016,"marketCap":1321503253376,"floatMarketCap":1269475362688,"timestamp":1777486575884,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":0,"down":7,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631549799","title":"Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2631549799","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631549799?lang=en_us&edition=fundamental","pubTime":"2026-04-30 00:02","pubTimestamp":1777478520,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S slipped 3.6% to DKK255.55 Wednesday on what proved to be an overall unfavorable trading session for the stock market, with the OMX Nordic 40 Index falling 0.5% to 2,553.49.The stock's fall  snapped a three-day winning streak.The company closed DKK277.85 below its 52-week high of DKK533.40, which the company achieved on June 13, 2025.Trading volume was 4,715,908, compared to the 50-day average trading volume of 7,366,276.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LU0154236417.USD","LU1093756325.SGD","BK4532","IE00BZ1G4Q59.USD",".DJI","NVO","DJX","NVOH","NVOX","BK4588","BK4599","IE00BKVL7J92.USD","LU1093756168.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631754669","title":"Eli Lilly Stock (LLY) Falls as Canada Approves Generic Weight-Loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2631754669","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631754669?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:21","pubTimestamp":1777476076,"startTime":"0","endTime":"0","summary":"Cheaper generic obesity drugs are expected to compete against name brand versions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-as-canada-approves-generic-weight-loss-drugs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-stock-lly-falls-as-canada-approves-generic-weight-loss-drugs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134952.CNY","LU1804176565.USD","LLII","LU2265009873.SGD","LU2602419157.SGD","LU0094547139.USD","LU0354030511.USD","LU1712237335.SGD","LU2211815571.USD","LU1127390331.HKD","LU0097036916.USD","LU0320765992.SGD","LU0203201768.USD","LU1917777945.USD","LU0234572021.USD","LU0203202063.USD","LU2237443382.USD","IE00BK4W5M84.HKD","LU0266013472.USD","LU0238689110.USD","LU1267930730.SGD","LU0820562030.AUD","SGXZ57979304.SGD","LU0106261372.USD","LU1035775433.USD","LU0820561909.HKD","LU0158827781.USD","LLY","LU1814569148.SGD","LU2417539215.USD","LU2168563687.JPY","LU2468319806.SGD","LU2462157665.USD","LU1988902786.USD","LU2750360997.AUD","LU1868836591.USD","LU1093756168.USD","LU2168564222.USD","IE0004445239.USD","LU2168564149.EUR","LU1868837136.USD","LU2271345857.HKD","LU2357305700.SGD","LU2112291526.USD","LU0471298694.HKD","IE00BKDWB100.SGD","SGXZ31699556.SGD","LU2264538146.SGD","LU1064131342.USD","LU2106854487.HKD","LU2360106947.USD","LU2456880835.USD","LU0114720955.EUR","LU1366192091.USD","IE00BFSS8Q28.SGD","LU0158827948.USD","BK4534","LU2756315664.SGD","IE0004445015.USD","ELIL","IE00BFTCPJ56.SGD","SG9999001176.USD","IE00B1XK9C88.USD","LU2023250330.USD","IE00B1BXHZ80.USD","LU2108987350.USD","LU0672654240.SGD","BK4588","LU0471298777.SGD","LU0882574055.USD","LU2461242641.AUD","SG9999001176.SGD","IE00BFSS7M15.SGD","LU0889565916.HKD","LU1291159041.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0353189680.USD","SG9999018865.SGD","SG9999014880.SGD","LU1551013425.SGD","SG9999017495.SGD","LU0708995401.HKD","LU0006306889.USD","LU0417517546.SGD","IE00B2B36J28.USD","LU2237443895.HKD","LU1280957306.USD","IE00BN29S564.USD","SGXZ99366536.SGD","LU2361045086.USD","SG9999018857.SGD","LU1232071149.USD","LU1720051017.SGD","LU2111349929.HKD","IE0002141913.USD","LU2023251221.USD","LU0096364046.USD","LU2471134796.USD","LU0964807845.USD","BK4007","LU0210536198.USD","IE00BJJMRX11.SGD","LU0320765059.SGD","LU2491049909.HKD","SGXZ51526630.SGD","LU0289739699.SGD","LU2237443978.SGD","IE00BKPKM429.USD","LU2491050154.USD","LU2324357040.USD","LU2028103732.USD","IE0005OL40V9.USD","BK4516","LU0882574139.USD","LU1629891620.HKD","LU2237443549.SGD","IE00BK4W5L77.USD","LLYZ","SG9999014898.SGD","LU1023059063.AUD","LU1061106388.HKD","LU1323610961.USD","IE0001KFT4U8.USD","LU0256863902.USD","LU0823434740.USD","LU2361044949.HKD","IE0009355771.USD","SGXZ81514606.USD","GB00BDT5M118.USD","SG9999015978.USD","LU1989771016.USD","LU2168564495.EUR","LU0689472784.USD","LU2471134879.HKD","LU2552382215.SGD","LU2896262040.SGD","LU1057294990.SGD","LU0316494557.USD","LU1548497426.USD","LU2236285917.USD","LU0786609619.USD","IE00BJJMRZ35.SGD","SG9999014914.USD","LU1093756325.SGD","LU0133085943.USD","LU2168564065.EUR","LU2491050071.SGD","LU2746668461.USD","SG9999014906.USD","ELIS","LU2746668974.SGD","LU0225283273.USD","LU1868836757.USD","LU0109394709.USD","SG9999015952.SGD","LU2756315318.SGD","LU1868836914.USD","IE00B7KXQ091.USD","LU0787776722.HKD","IE00BJLML261.HKD","BK4599","SG9999015986.USD","LU2089283258.USD","LU0058720904.USD","LU2237443622.USD","IE00B4R5TH58.HKD","LU0432979614.USD","IE00BJJMRY28.SGD","SG9999015945.SGD","LU1145028129.USD","LU2361044865.SGD","LU0385154629.USD","IE00BWXC8680.SGD","LU0122379950.USD","LU0323591593.USD","LU0683600562.USD","LU2552382058.USD","LU2237438978.USD","LU0256863811.USD","LU0079474960.USD","IE00B4JS1V06.HKD","LU0823416689.USD","LU1551013342.USD","LU2213496289.HKD","LU1069344957.HKD","LU0466842654.USD","LU1623119135.USD","LU0109391861.USD","LU0820561818.USD","LU1868837300.USD","LU1974910355.USD","LU0943347566.SGD","LU2089284900.SGD","LU2471134523.USD","LU2750360641.GBP","LU0640476718.USD","LU1720051108.HKD","LU2089984988.USD","LU2552382132.HKD","LU0061475181.USD","LU1983299246.USD","BK4533","LU2237443465.HKD","SG9999013999.USD","BK4581","LU0353189763.USD","LU0198837287.USD","LLYX","LU0354030438.USD","LU2023250504.SGD","LU0823434583.USD","LU2063271972.USD","IE00B775H168.HKD","LU2087625088.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545104","title":"MDB Capital report says retatrutide hits 28.7% weight loss, shifts obesity drug race to IP","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545104","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631545104?lang=en_us&edition=fundamental","pubTime":"2026-04-29 23:00","pubTimestamp":1777474858,"startTime":"0","endTime":"0","summary":"MDB Capital-backed PatentVest published an industry analysis on obesity drug competition following Eli Lilly retatrutide posting 28.7% mean weight loss in April 2026, matching bariatric outcomes in trials.Report said competitive focus is shifting from clinical efficacy to intellectual-property control, including who can operate around patents or gets blocked from market entry.Analysis cited 27 programs targeting triple-agonist mechanisms, with Novo Nordisk building a multi-asset portfolio while Pfizer entered via acquisition.PatentVest said real-world performance is expected to fall short of trial results, framing adherence and outcomes gap as key battleground for value capture.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL6fvfNn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2211815571.USD","LU0417517546.SGD","SGXZ81514606.USD","IE00BN29S564.USD","LU0321505439.SGD","IE0001KFT4U8.USD","LU2089284900.SGD","IE00BN0W2W23.USD","LU0158827948.USD","LU0432979614.USD","LU2213496289.HKD","SG9999015945.SGD","LU0820561909.HKD","LU1868836757.USD","SGXZ57979304.SGD","LU1145028129.USD","IE00BFSS7M15.SGD","LU1623119135.USD","IE00BJJMRX11.SGD","LU0708995401.HKD","LU0256863902.USD","IE00BBT3K403.USD","LU0820561818.USD","LU1804176565.USD","IE0004445239.USD","LU0354030438.USD","LU1983299246.USD","LU2237443895.HKD","LU2746668974.SGD","LU0238689110.USD","LU0640476718.USD","LU2750360997.AUD","IE00B775H168.HKD","LU2456880835.USD","SG9999001176.USD","SG9999003800.SGD","LU2237443978.SGD","LU0122379950.USD","LU2756315318.SGD","LU0985481810.HKD","LU2361044865.SGD","IE0004445015.USD","LU1093756168.USD","LU2237438978.USD","MDBH","SGXZ99366536.SGD","IE00B3QW5Z07.USD","LU1629891620.HKD","LU2750360641.GBP","LU2357305700.SGD","LLY","IE0009355771.USD","LU1023059063.AUD","IE00BFSS8Q28.SGD","LU2236285917.USD","LU1894683264.USD","LU2471134523.USD","LU0320765992.SGD","SG9999014880.SGD","LU1291159041.SGD","IE00BJJMRY28.SGD","LU2552382215.SGD","BK4533","LU2237443622.USD","SG9999018865.SGD","SG9999017495.SGD","IE00BN0W2T93.GBP","ELIL","IE00BJJMRZ35.SGD","LU0133085943.USD","LU1280957306.USD","LU2324357040.USD","LU0353189680.USD","IE000M9KFDE8.USD","LU1988902786.USD","SG9999014021.USD","LU0106261372.USD","LU0868494617.USD","LU1232071149.USD","LU2111349929.HKD","LU2168563687.JPY","LU2271345857.HKD","LU0225284248.USD","IE00B1BXHZ80.USD","LU0256863811.USD","LU1366192091.USD","LLYZ","LU0314104364.USD","LU1061106388.HKD","LU2168564149.EUR","LU2756315664.SGD","LLII","LU1064131342.USD","LU0109394709.USD","LU0203202063.USD","BK4112","LU2361045086.USD","LU1551013425.SGD","SG9999014039.USD","LU0456855351.SGD","LU2063271972.USD","LU0094547139.USD","SG9999014013.SGD","BK4588","IE00B1XK9C88.USD","LU1974910355.USD","LU0820562030.AUD","IE00BKDWB100.SGD","LU0109391861.USD","LU0786609619.USD","SG9999014898.SGD","LU2360106947.USD","LU1548497426.USD","LU1868836591.USD","LU0321505868.SGD","LU2361044949.HKD","LU0114720955.EUR","SG9999011175.SGD","IE00BK4W5M84.HKD","LU0471298777.SGD","LU2471134952.CNY","LU2491050071.SGD","LU2168564222.USD","LU0320765059.SGD","SG9999002232.USD","LU2471134879.HKD","SGXZ31699556.SGD","LU1883839398.USD","LU2210150020.SGD","IE0005OL40V9.USD","LU2112291526.USD","LU0471298694.HKD","LU2746668461.USD","LU0096364046.USD","IE00BJLML261.HKD","LU1066053197.SGD","LU2210149790.SGD","LU0683600562.USD","LU2462157665.USD","IE00BWXC8680.SGD","LU1066051498.USD","IE00BN0W2V16.EUR","IE00B2B36J28.USD","BK4007","IE00B19Z3581.USD","LU1057294990.SGD","LU2237443465.HKD","SG9999014914.USD","LU2023250330.USD","LU0689472784.USD","LU2023250504.SGD","LU2095319765.USD","LU2168564495.EUR","LU2237443549.SGD","LU0354030511.USD","IE00BK4W5L77.USD","LU0306806265.USD","LU2108987350.USD","LU0823434740.USD","IE00BJT1NW94.SGD","BK4585","LU1093756325.SGD","SG9999001176.SGD","LU0882574055.USD","LU1712237335.SGD","LU2417539215.USD","SG9999013999.USD","LU0964807845.USD","LU2089984988.USD","LU0170899867.USD","LU1720051108.HKD","LU0225283273.USD","LU1551013342.USD","IE00B7KXQ091.USD","LU0234572021.USD","IE00B4JS1V06.HKD","IE00BKPKM429.USD","LU0323591593.USD","BK4599","IE00BLSP4239.USD","LU0058720904.USD","IE0002141913.USD","LU2168564065.EUR","SG9999015986.USD","LU2237443382.USD","LU1720051017.SGD","LU2023251221.USD","LU1814569148.SGD","IE00B19Z3B42.SGD","LU1127390331.HKD","LU2106854487.HKD","LU0889565916.HKD","LU2087625088.SGD","SG9999015952.SGD","LU0316494557.USD","LU1069344957.HKD","IE0002270589.USD","IE00B4R5TH58.HKD","LU1868837136.USD","SG9999015978.USD","LU0466842654.USD","LU1323610961.USD","LU2552382058.USD","BK4534","LU2552382132.HKD","LU2461242641.AUD","LU2491049909.HKD","LU0353189763.USD","LU1267930730.SGD","LU0306807586.USD","LU0672654240.SGD","LU0061475181.USD","SGXZ51526630.SGD","LU2089283258.USD","LU2028103732.USD","SG9999014906.USD","BK4581","LU0943347566.SGD","LU2602419157.SGD","BK4592","LLYX","LU0006306889.USD","LU1894683348.USD","LU0225771236.USD","SG9999018857.SGD","LU0882574139.USD","GB00BDT5M118.USD","LU0266013472.USD","LU2468319806.SGD","LU0097036916.USD","LU1035775433.USD","LU2471134796.USD","BK4127","LU1917777945.USD","SG9999002224.SGD","ELIS","LU2491050154.USD","BK4568","BK4550","LU0079474960.USD","LU2896262040.SGD","LU0158827781.USD","LU2265009873.SGD","LU0289739699.SGD","IE00BGHQF748.EUR","LU0203201768.USD","IE00BLSP4452.SGD","LU0385154629.USD","LU1989771016.USD","LU2264538146.SGD","LU1868837300.USD","SG9999014005.SGD","IE00BFTCPJ56.SGD","LU0823434583.USD","IE00B64PRP62.GBP","LU1868836914.USD","LU0823416689.USD","LU0787776722.HKD","LU0198837287.USD","LU0210536198.USD","BK4516"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631551184","title":"3SBio publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631551184","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631551184?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:23","pubTimestamp":1777465417,"startTime":"0","endTime":"0","summary":"3SBio annual report for year ended Dec. 31, 2025 flagged record results, driven by core product momentum and global licensing collaboration with Pfizer for PD-1/VEGF bispecific antibody 707.707 out-license granted Pfizer exclusive rights outside Mainland China, with 3SBio retaining rights in Mainland China.Transaction delivered front-end payments of USD 1.5 billion, with potential milestones exceeding USD 4.8 billion.Pipeline advanced with two marketing approvals in 2025, with additional filings submitted for late-stage candidates including 613, 611, 601A.Board proposed final dividend of HKD 0.25 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 3SBio Inc. published the original content used to generate this news brief via IIS,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL7t7zFb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066051498.USD","LU0985481810.HKD","LU1894683348.USD","IE00BBT3K403.USD","BK4588","SG9999011175.SGD","LU0058720904.USD","SG9999001176.USD","BK1583","LU0225284248.USD","IE00B19Z3B42.SGD","BK4581","LU0321505868.SGD","LU0321505439.SGD","BK4550","LU0225771236.USD","BK4592","BK1593","LU1057294990.SGD","SG9999002232.USD","LU0306807586.USD","BK4007","BK4568","HK0000165453.HKD","IE00BLSP4239.USD","LU0234572021.USD","BK4585","LU1066053197.SGD","BK4534","BK1161","LU0456855351.SGD","IE00BLSP4452.SGD","LU0122379950.USD","IE0002270589.USD","LU1894683264.USD","LU0868494617.USD","LU1883839398.USD","IE00B19Z3581.USD","SG9999003800.SGD","LU0306806265.USD","SG9999001176.SGD","SGXZ57979304.SGD","SG9999002224.SGD","BK4599","IE000M9KFDE8.USD","BK4533","LU0170899867.USD","LU0289739699.SGD","01530","SG9999013999.USD","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631516625","title":"RPT-BREAKINGVIEWS-Quantum computing awaits its ChatGPT moment","url":"https://stock-news.laohu8.com/highlight/detail?id=2631516625","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631516625?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:00","pubTimestamp":1777464000,"startTime":"0","endTime":"0","summary":"RPT-BREAKINGVIEWS-Quantum computing awaits its ChatGPT momentThe author is a Reuters Breakingviews columnist. The opinions expressed are his own.By Pranav KiranTORONTO, April 28  (Reuters Breakingview","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nL6N41B19T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00BK4W5L77.USD","LU1551013425.SGD","IONQ","LU0128525689.USD","BK4007","IE00BDRTCR15.USD","LU0057025933.USD","LU1989772840.SGD","LU0211331839.USD","LU0648001328.SGD","LU1935042215.USD","IE00BMPRXR70.SGD","LU0672654240.SGD","LU0048584097.USD","LU1868837300.USD","LU1868837136.USD","LU2125909247.SGD","IE00BBT3K403.USD","IE000BZT7R73.USD","IE00B19Z3581.USD","LU1935043536.SGD","LU0345774391.USD","LU1935042488.USD","LU2023250504.SGD","IE00BLSP4452.SGD","RGTI","BK4206","LU0980610538.SGD","LU0689472784.USD","SG9999018865.SGD","LU2247934214.USD","SG9999011175.SGD","LU1221951129.SGD","LU2403377893.USD","LU0476273544.USD","LU0889566641.SGD","IONZ","LU0957791311.USD","LU0354030438.USD","SG9999014880.SGD","BK4532","LU0210533765.USD","LU1435385759.SGD","SGXZ51526630.SGD","IE0000B7K699.USD","SGXZ99366536.SGD","IE00BJLML261.HKD","LU2054465674.USD","LU0265550946.USD","LU2471134879.HKD","LU2213496289.HKD","LU0314104364.USD","SG9999002232.USD","LU1059921491.USD","LU2271345857.HKD","LU1235294995.USD","LU0985481810.HKD","LU1791710400.SGD","LU0426417589.USD","SG9999014898.SGD","BK4575","LU2023250843.SGD","SG9999013999.USD","LU0251132253.USD","IE00BK4W5M84.HKD","IE00BKVL7J92.USD","LU2168564495.EUR","LU0052756011.USD","LU2125909593.SGD","GOOY","LU0784384876.USD","LU1674673691.USD","LU2265009873.SGD","LU1261432733.SGD","BK4141","LU0689626769.HKD","LU0208291251.USD","QBTZ","LU2023251221.USD","LU2602419157.SGD","LU0158827781.USD","LU2237438978.USD","LU1267930813.SGD","GB00B4LPDJ14.GBP","LU0949170772.SGD","BK4543","LU0456855351.SGD","LU0312595415.SGD","LU0787776722.HKD","SG9999015978.USD","LU0661504455.SGD","LU0553294199.USD","LU0985320562.USD","LU1201861249.SGD","LU1989764748.USD","IE00B1XK9C88.USD","LU1400636491.USD","SGXZ31699556.SGD","LU1585245621.USD","GOOP","LU0198837287.USD","LU1548497426.USD","IE000SO60NU8.SGD","LU2471134952.CNY","LU2491050154.USD","LU0077335932.USD","IE00B19Z8W00.USD","IE00BQXX3C00.GBP","LU0265550359.USD","LU0310800965.SGD","LU1066053197.SGD","LU2028103732.USD","BK4538","LU0127658192.USD","LU2111349929.HKD","LU1823568750.SGD","SG9999014906.USD","LU1868836757.USD","LU0251142724.SGD","LU1323610961.USD","IE000MB6IJN5.SGD","LU0784383803.USD","IE0034235188.USD","BK4608","LU1571399168.USD","LU2860962120.EUR","LU0426412945.USD","LU0496365809.HKD","LU1880398471.USD","LU0302445910.USD","LU1496350502.SGD","LU2462591350.SGD","BK4561","LU1232071149.USD","LU0348723411.USD","LU1670628061.USD","LU1914381329.SGD","LU0976567544.SGD","LU1894683264.USD","LU0321505439.SGD","LU2491050071.SGD","SG9999015986.USD","SG9999001176.SGD","QBY","LU0823421416.USD","QBTS","GB00B4QBRK32.GBP","BK4512","BK4579","LU1267930730.SGD","BK4576","LU0943347566.SGD","LU1791710582.SGD","LU0417517546.SGD","LU0306806265.USD","LU0528227936.USD","LU1084165304.USD","LU0157215616.USD","LU0477156953.USD","LU0211327993.USD","LU0345768740.USD","LU2746668974.SGD","LU0267386448.USD","BK4514","LU0276348264.USD","BK4592","LU1720051017.SGD","LU1267930573.SGD","LU0058720904.USD","LU0683600562.USD","LU0345770993.USD","LU1400636574.HKD","LU1883839398.USD","LU2471134523.USD","IONX","LU0122379950.USD","BK4574","IE00BJTD4V19.USD","LU2404859741.USD","GOOGL","LU0820561909.HKD","LU0289961442.SGD","LU0256863902.USD","GOOW","BK4581","LU1316542783.SGD","LU0994945656.USD","LU2360032135.SGD","IE0034235303.USD","LU2750360997.AUD","IE00B19Z9505.USD","IE00B19Z8X17.USD","BK4534","LU1989772923.USD","LU0820562030.AUD","LU0097036916.USD","LU1145028129.USD","LU2362540622.SGD","LU1121112475.USD","LU0056508442.USD","LU0061474960.USD","LU0225284248.USD","LU2098885051.SGD","LU2456880835.USD","LU1023059063.AUD","LU0823434740.USD","LU0080751232.USD","BK4585","IE00BMPRXN33.USD","BK4077","LU2250418816.HKD","SG9999001176.USD","LU0310800379.SGD","LU1066051498.USD","LU2065171311.SGD","LU1301847155.USD","LU1043141123.HKD","BK4599","LU0109391861.USD","LU2362541513.USD","SG9999017495.SGD","LU1868836914.USD","LU0130103400.USD","BK4568","IE0034235295.USD","LU1778281490.HKD","IE000WAW04H5.SGD","LU2362541273.HKD","LU1935042991.SGD","LU1032955483.USD","LU0289739699.SGD","LU0321505868.SGD","IE0001KFT4U8.USD","GOOX","LU1066051225.USD","LU1551013342.USD","LU1839511570.USD","LU0323591593.USD","LU0444973449.USD","LU0823434583.USD","LU0949170426.SGD","LU0130518102.USD","LU0345768153.USD","SG9999015952.SGD","LU0477156797.USD","LU0096364046.USD","LU2491049909.HKD","LU2065169927.USD","IE00B1BXHZ80.USD","LU0203345920.USD","LU2236285917.USD","LU0345769631.USD","LU2471134796.USD","LU2462591277.SGD","LU0320765489.SGD","LU2430703178.SGD","LU1804176565.USD","SGXZ81514606.USD","BK4566","GGLS","LU0466842654.USD","LU0306807586.USD","LU0820561818.USD","LU2746668461.USD","SG9999002224.SGD","LU0203347892.USD","LU1267930227.SGD","LU1699723380.USD","LU2999663052.SGD","BK4170","LU2430703251.USD","LU0130102774.USD","GOU","LU0868494617.USD","LU1720051108.HKD","IE00BFMHRM44.USD","LU0823421333.USD","LU2242650005.HKD","LU1244550221.USD","LU0158827948.USD","LU2087621335.USD","LU1093756325.SGD","LU1244550577.SGD","LU1670627923.USD","GGLL","LU0882574139.USD","LU0353189763.USD","LU1894683348.USD","LU2592432038.USD","LU0289960550.SGD","LU1196500208.SGD","LU1951200564.SGD","LU0211328371.USD","BK4023","LU1093756168.USD","LU1803068623.USD","IE0002270589.USD","LU0690374615.EUR","IOYY","LU2433249047.HKD","LU1988902786.USD","LU1119994496.HKD","LU0187121727.USD","LU2087625088.SGD","LU2211815571.USD","LU0061474705.USD","LU0174119429.USD","LU1935043023.USD","LU1267930490.SGD","LU2756315318.SGD","LU2023250330.USD","LU2065171402.SGD","LU2097829019.USD","LU2168563687.JPY","LU2242649171.HKD","LU2954938101.SGD","HK0000532082.HKD","LU1046421795.USD","LU1923622614.USD","BK4588","LU0792757196.USD","LU2326559502.SGD","LU0708995401.HKD","LU0964807845.USD","LU0354030511.USD","LU2168564149.EUR","LU2275660780.HKD","BK4527","SG9999015945.SGD","LU0444971666.USD","LU0070302665.USD","LU1923623000.USD","LU1366192091.USD","LU1815333072.USD","LU2168564065.EUR","LU0957808578.USD","LU0149725797.USD","LU0124676726.USD","IE00BKDWB100.SGD","LU1989764664.SGD","LU2125154778.USD","LU1718418525.SGD","SG9999003800.SGD","LU0251131958.USD","LU2097344431.USD","IE000F7OJYX1.SGD","LU0289739343.SGD","LU0345770308.USD","LU1064131342.USD","LU0011850046.USD","LU1496350171.SGD","LU0069063385.USD","LU2264538146.SGD","LU0742534661.SGD","LU0345769128.USD","LU2191332357.HKD","LU0942090050.USD","LU1506573853.SGD","IE00BHPRN162.USD","LU0868494708.USD","LU0511384066.AUD","IE00BMPRXQ63.HKD","LU0061475181.USD","QBTX","LU1244550494.USD","LU1974910355.USD","LU0642271901.SGD","LU0310799852.SGD","RGTX","SG9999014914.USD","LU1366333091.USD","BK4602","LU2381873111.SGD","LU2756315664.SGD","LU0640476718.USD","LU0154236417.USD","LU0648000940.SGD","LU0545039389.USD","LU2505996681.GBP","LU0225283273.USD","BK4612","HK0000304797.USD","LU0130517989.USD","IE00BLSP4239.USD","IE0004086264.USD","LU2417539215.USD","LU0096362180.USD","LU2089284900.SGD","LU2065170008.USD","LU1868836591.USD","RGTZ","LU1670756490.USD","LU2420271590.USD","LU0225771236.USD","HK0000819398.USD","LU0494093205.USD","LU2106854487.HKD","SG9999018857.SGD","LU2244417387.USD","LU1917777945.USD","RGTU","IE00BJTD4N35.SGD","LU1645745479.HKD","LU1280957306.USD","LU1951198990.SGD","LU0128525929.USD","LU1880398554.USD","LU0170899867.USD","LU0708994859.HKD","LU0106261372.USD","LU0215105999.USD","LU2404859667.USD","SGXZ57979304.SGD","LU1852331112.SGD","IE00B7SZLL34.SGD","IE00BDCRKT87.USD","LU0784385170.HKD","LU2089283258.USD","LU1116320737.USD","LU2360106780.USD","BK4533","HK0000304805.HKD","IE00BN8TJ469.HKD","IONL","LU0107464264.USD","LU0314106906.USD","LU1221951046.USD","BK4134","IE00BSNM7G36.USD","BK4591","LU0175139822.USD","LU2168564222.USD","LU1202635105.USD","LU1642822529.SGD","LU2063271972.USD","LU0234570918.USD","LU1003077747.HKD","LU2750360641.GBP","LU1043141396.HKD","LU2092937148.SGD","IE00BWXC8680.SGD","LU2092627202.USD","BK4598","LU0138981039.USD","LU1429558221.USD","LU0048573561.USD","LU0211326839.USD","LU0557290698.USD","IE00B19Z3B42.SGD","LU1066051811.HKD","IE0004091025.USD","LU0316494557.USD","LU0784385840.USD","LU1303367103.USD","LU2505996509.AUD","LU0029864427.USD","LU2462157665.USD","IE00BQXX3D17.EUR","BK4573","IE00BYXW3230.USD","LU1116320901.HKD","LU1430594728.SGD","LU0006306889.USD","LU1400636657.SGD","BK4503","LU2357305700.SGD","LU2430703095.HKD","LU1674673428.USD","LU0738911758.USD","BK4550","SG9999000418.SGD","LU0094547139.USD","LU0320765059.SGD","LU1815336760.USD","IBM","LU1201861165.SGD","LU0345774631.USD","RGYY","LU0143551892.USD","LU0070217475.USD","LU0211326755.USD","LU1629891620.HKD","IE00BZ1G4Q59.USD","LU1633808545.USD","LU0234572021.USD","LU0472753341.HKD","LU0342679015.USD","LU1153585028.USD","LU1057294990.SGD","LU0256863811.USD","LU0690374961.EUR","LU2125154935.USD","LU2077746001.SGD","LU2097344357.USD","LU0353189680.USD","IE00BQXX3F31.USD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631515322","title":"Pfizer's blood cancer drug meets main goal in late-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2631515322","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631515322?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:39","pubTimestamp":1777462799,"startTime":"0","endTime":"0","summary":"Pfizer's blood cancer drug meets main goal in late-stage trialApril 29  - Pfizer PFE.N said on Wednesday its drug Elrexfio met the main goal in a late-stage trial that tested the blood cancer treatment in patients who received at least one prior line of treatment.Here are further details on the trial:Elrexfio has the U.S. Food and Drug Administration's accelerated approval for treating patients with multiple myeloma who have received at least four prior lines of treatment.Multiple myeloma is a cancer of the plasma cells, a type of white blood cell in the bone marrow that helps fight infection.Pfizer said the drug showed clinically meaningful improvement in progression free survival, or living without the disease worsening, when compared to standard of care treatment.The trial remains ongoing to assess overall survival, a key secondary goal, as the data was not yet available at the time of this interim analysis, the company said.The company said the trial data will be discussed with glo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nL4N41C19D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","BK4550","LU0225284248.USD","BK4007","IE00BLSP4452.SGD","LU0122379950.USD","SG9999002224.SGD","LU1066051498.USD","LU0306806265.USD","LU0321505439.SGD","LU0321505868.SGD","BK4534","LU0234572021.USD","SGXZ57979304.SGD","LU1883839398.USD","LU0225771236.USD","SG9999001176.USD","LU0289739699.SGD","IE00BLSP4239.USD","IE00BBT3K403.USD","IE0002270589.USD","LU1894683264.USD","SG9999013999.USD","LU0456855351.SGD","BK4592","BK4533","LU1023059063.AUD","IE00B19Z3B42.SGD","BK4585","BK4568","BK4599","BK4581","SG9999011175.SGD","LU0058720904.USD","PFE","LU0306807586.USD","SG9999002232.USD","LU1066053197.SGD","LU0170899867.USD","IE000M9KFDE8.USD","LU0868494617.USD","IE00B19Z3581.USD","SG9999003800.SGD","LU1057294990.SGD","SG9999001176.SGD","LU1894683348.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631590198","title":"Pfizer price target raised to $27 from $26 at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2631590198","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631590198?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:59","pubTimestamp":1777460397,"startTime":"0","endTime":"0","summary":"Citi analyst Geoff Meacham raised the firm’s price target on Pfizer (PFE) to $27 from $26 and keeps a Neutral rating on the shares. Published first...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-price-target-raised-to-27-from-26-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-price-target-raised-to-27-from-26-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0456855351.SGD","LU0321505868.SGD","SG9999001176.SGD","IE00BLSP4452.SGD","BK4007","LU1057294990.SGD","SG9999003800.SGD","BK4585","IE0002270589.USD","LU1066051498.USD","LU1883839398.USD","SG9999001176.USD","IE000M9KFDE8.USD","LU0225771236.USD","LU0225284248.USD","PFE","LU1894683264.USD","LU0122379950.USD","BK4534","BK4599","LU0289739699.SGD","LU0234572021.USD","LU1894683348.USD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","BK4568","BK4588","LU0058720904.USD","LU0306806265.USD","LU0868494617.USD","LU0321505439.SGD","BK4550","LU0170899867.USD","BK4533","LU1023059063.AUD","SG9999002232.USD","LU0306807586.USD","BK4581","IE00BLSP4239.USD","IE00BBT3K403.USD","LU1066053197.SGD","SG9999013999.USD","LU0985481810.HKD","SG9999002224.SGD","SG9999011175.SGD","BK4592","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631359756","title":"Pfizer says Phase 3 MagnetisMM-5 trial meets primary endpoint for ELREXFIO in myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2631359756","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631359756?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:46","pubTimestamp":1777459592,"startTime":"0","endTime":"0","summary":"Pfizer reported positive interim topline results from Phase 3 MagnetisMM-5 trial of ELREXFIO in relapsed or refractory multiple myeloma patients who had received at least one prior treatment line.Study met primary endpoint, showing ELREXFIO kept disease under control longer than standard regimen of daratumumab, pomalidomide, dexamethasone.Safety profile matched prior experience, with no new safety signals flagged.Results have not yet been presented; detailed findings will be submitted for presentation at a future medical congress.Trial continues to evaluate overall survival, which remains a key secondary endpoint.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL3TqhsT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BLSP4239.USD","LU0122379950.USD","BK4581","IE00B19Z3B42.SGD","SG9999002232.USD","BK4007","BK4550","LU0306807586.USD","SG9999011175.SGD","LU0985481810.HKD","IE00BBT3K403.USD","LU1894683348.USD","IE00B19Z3581.USD","BK4599","IE000M9KFDE8.USD","SGXZ57979304.SGD","LU0289739699.SGD","BK4533","LU0058720904.USD","BK4588","LU1894683264.USD","LU0225284248.USD","LU1066051498.USD","LU0321505439.SGD","LU0868494617.USD","SG9999001176.SGD","SG9999002224.SGD","PFE","SG9999013999.USD","BK4592","LU1066053197.SGD","LU1057294990.SGD","LU0321505868.SGD","LU0456855351.SGD","IE00BLSP4452.SGD","IE0002270589.USD","LU0225771236.USD","BK4568","SG9999001176.USD","LU0306806265.USD","LU0234572021.USD","LU1883839398.USD","LU1023059063.AUD","LU0170899867.USD","BK4585","SG9999003800.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631870597","title":"Pfizer - Elrexfio Demonstrates Superior Progression-Free Survival Versus Standard-of-Care Dpd","url":"https://stock-news.laohu8.com/highlight/detail?id=2631870597","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631870597?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:45","pubTimestamp":1777459500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA1KKBKW:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0225771236.USD","LU0234572021.USD","LU0306807586.USD","LU0306806265.USD","LU1057294990.SGD","LU1894683348.USD","LU0985481810.HKD","SGXZ57979304.SGD","LU1066051498.USD","LU0868494617.USD","LU0321505868.SGD","SG9999001176.USD","LU1894683264.USD","BK4533","IE00B19Z3B42.SGD","SG9999001176.SGD","SG9999011175.SGD","BK4534","SG9999013999.USD","IE00BLSP4239.USD","BK4585","IE00BLSP4452.SGD","LU0289739699.SGD","LU0456855351.SGD","BK4568","LU0225284248.USD","BK4550","LU0122379950.USD","BK4588","LU1023059063.AUD","BK4007","SG9999003800.SGD","IE00B19Z3581.USD","IE000M9KFDE8.USD","SG9999002224.SGD","LU0058720904.USD","SG9999002232.USD","IE00BBT3K403.USD","PFE","IE0002270589.USD","LU0321505439.SGD","LU1883839398.USD","BK4581","LU0170899867.USD","LU1066053197.SGD","BK4592","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631597824","title":"Pfizer - No New Safety Signals Identified for Elrexfio in Magnetismm-5 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2631597824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631597824?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:45","pubTimestamp":1777459500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA1KKBKW:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0456855351.SGD","LU1057294990.SGD","LU1066053197.SGD","LU0225771236.USD","SG9999013999.USD","BK4534","LU0122379950.USD","LU0306806265.USD","SG9999002224.SGD","LU0225284248.USD","LU0985481810.HKD","SG9999001176.SGD","IE00B19Z3581.USD","LU1883839398.USD","BK4568","LU0289739699.SGD","BK4550","LU0321505439.SGD","PFE","LU0058720904.USD","BK4581","BK4007","IE00BLSP4452.SGD","LU0868494617.USD","SG9999001176.USD","BK4588","IE00BLSP4239.USD","LU0321505868.SGD","LU0306807586.USD","BK4599","LU1894683348.USD","BK4592","SG9999002232.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","BK4585","IE00B19Z3B42.SGD","LU1894683264.USD","LU1066051498.USD","SG9999003800.SGD","SG9999011175.SGD","IE00BBT3K403.USD","IE0002270589.USD","LU0234572021.USD","LU1023059063.AUD","LU0170899867.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631597822","title":"Pfizer - Magnetismm-5 Trial Meets Primary Endpoint at Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2631597822","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631597822?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:45","pubTimestamp":1777459500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA1KKBKW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LU0058720904.USD","BK4588","SG9999001176.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","BK4592","IE0002270589.USD","BK4585","LU0234572021.USD","IE000M9KFDE8.USD","SG9999002232.USD","LU0456855351.SGD","IE00BLSP4239.USD","LU0321505439.SGD","LU0321505868.SGD","BK4568","LU1066053197.SGD","BK4581","SG9999002224.SGD","BK4550","LU0225771236.USD","LU0306807586.USD","LU0985481810.HKD","LU1894683348.USD","IE00BLSP4452.SGD","PFE","LU0122379950.USD","LU0868494617.USD","BK4533","BK4599","SG9999001176.SGD","LU1023059063.AUD","LU1066051498.USD","SG9999011175.SGD","LU0225284248.USD","LU0306806265.USD","SG9999003800.SGD","LU1057294990.SGD","LU1894683264.USD","LU1883839398.USD","BK4534","LU0170899867.USD","SGXZ57979304.SGD","SG9999013999.USD","LU0289739699.SGD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631597815","title":"Pfizer’s Elrexfio Significantly Improves Progression-Free Survival for Double-Class Exposed Patients With Relapsed or Refractory Multiple Myeloma","url":"https://stock-news.laohu8.com/highlight/detail?id=2631597815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631597815?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:45","pubTimestamp":1777459500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA1KKBKW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BLSP4239.USD","LU0225284248.USD","LU0289739699.SGD","SG9999003800.SGD","LU1883839398.USD","LU1894683264.USD","BK4550","IE00B19Z3581.USD","BK4534","BK4592","LU0122379950.USD","LU0868494617.USD","LU1894683348.USD","LU0456855351.SGD","IE0002270589.USD","LU0321505439.SGD","LU1023059063.AUD","SG9999013999.USD","PFE","BK4599","LU0321505868.SGD","LU0306806265.USD","SG9999002224.SGD","LU0170899867.USD","SGXZ57979304.SGD","BK4533","LU1066053197.SGD","SG9999001176.SGD","IE00BBT3K403.USD","SG9999001176.USD","BK4585","IE00BLSP4452.SGD","LU1057294990.SGD","BK4581","BK4568","BK4588","LU0306807586.USD","IE000M9KFDE8.USD","SG9999002232.USD","SG9999011175.SGD","LU0225771236.USD","LU0058720904.USD","LU0985481810.HKD","LU1066051498.USD","BK4007","LU0234572021.USD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631597383","title":"Pfizer - Magnetismm-5 Trial Ongoing to Assess Overall Survival","url":"https://stock-news.laohu8.com/highlight/detail?id=2631597383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631597383?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:45","pubTimestamp":1777459500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nTUA1KKBKW:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0058720904.USD","LU1057294990.SGD","BK4599","SG9999001176.SGD","LU0234572021.USD","PFE","SG9999001176.USD","LU0170899867.USD","LU1883839398.USD","LU1894683264.USD","IE00BLSP4239.USD","LU0868494617.USD","SG9999003800.SGD","SG9999002232.USD","BK4588","LU0456855351.SGD","IE000M9KFDE8.USD","LU0321505439.SGD","LU0985481810.HKD","BK4568","LU0289739699.SGD","LU0225771236.USD","LU0225284248.USD","LU0306807586.USD","SGXZ57979304.SGD","LU1894683348.USD","BK4534","IE00B19Z3B42.SGD","IE00B19Z3581.USD","SG9999002224.SGD","LU1066053197.SGD","BK4581","LU0306806265.USD","BK4007","LU0321505868.SGD","BK4533","IE00BLSP4452.SGD","BK4592","BK4550","SG9999011175.SGD","IE0002270589.USD","LU1066051498.USD","BK4585","SG9999013999.USD","IE00BBT3K403.USD","LU1023059063.AUD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631059277","title":"Eli Lilly investors look for insight into Foundayo launch data, Reuters says","url":"https://stock-news.laohu8.com/highlight/detail?id=2631059277","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631059277?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:35","pubTimestamp":1777458953,"startTime":"0","endTime":"0","summary":"Following Q1 results, Eli Lilly (LLY) investors will be searching for insight into the launch of weight-loss pill Foundayo, Chris Prentice and Mari...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-investors-look-for-insight-into-foundayo-launch-data-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-investors-look-for-insight-into-foundayo-launch-data-reuters-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2237443465.HKD","SGXZ31699556.SGD","LU0122379950.USD","LU0672654240.SGD","IE00BFSS7M15.SGD","LU0106261372.USD","IE00BJLML261.HKD","LU0266013472.USD","LU1035775433.USD","LU0456855351.SGD","LU0964807845.USD","LU2417539215.USD","IE00B2B36J28.USD","IE00BKPKM429.USD","SGXZ99366536.SGD","LU1974910355.USD","LU2028103732.USD","LU0210536198.USD","LU0823416689.USD","LU2265009873.SGD","IE00B1BXHZ80.USD","SG9999018857.SGD","LU2237443549.SGD","LU0289739699.SGD","LU0354030438.USD","LU2106854487.HKD","LU0198837287.USD","SG9999001176.SGD","LU2324357040.USD","LU1057294990.SGD","LU2471134523.USD","IE00BWXC8680.SGD","LU2471134879.HKD","BK4588","LU0094547139.USD","LU2237438978.USD","BK4007","LU0471298694.HKD","LU2089283258.USD","LU0316494557.USD","LU1814569148.SGD","IE00BJJMRZ35.SGD","SG9999001176.USD","ELIS","LU1804176565.USD","LU0109391861.USD","BK4516","LU2750360641.GBP","LU1988902786.USD","IE00BJT1NW94.SGD","BK4534","LU2471134952.CNY","SGXZ81514606.USD","LU2361044949.HKD","LU0320765992.SGD","SGXZ57979304.SGD","LU0109394709.USD","LU0234572021.USD","LU1551013425.SGD","SG9999014914.USD","LU2213496289.HKD","LU2471134796.USD","SG9999018865.SGD","LU0683600562.USD","LU0203202063.USD","LU1127390331.HKD","LU2168564495.EUR","IE00BK4W5M84.HKD","LU1023059063.AUD","LU1232071149.USD","LU2089284900.SGD","LU2491050154.USD","LU2111349929.HKD","GB00BDT5M118.USD","LU0943347566.SGD","LU2023251221.USD","LU0786609619.USD","LU1712237335.SGD","LLII","LU1093756325.SGD","SG9999013999.USD","SG9999015978.USD","LU0823434740.USD","LU0097036916.USD","LU1548497426.USD","LU0323591593.USD","IE0005OL40V9.USD","LU0640476718.USD","LU2271345857.HKD","LU2896262040.SGD","LU0353189680.USD","IE0004445239.USD","BK4533","LU0158827948.USD","LU1720051017.SGD","LU1917777945.USD","LU1069344957.HKD","LU2361044865.SGD","BK4585","LLY","LU1868836591.USD","IE00BJJMRX11.SGD","LU2237443382.USD","LU1323610961.USD","LU2552382215.SGD","SG9999015945.SGD","LU1291159041.SGD","SGXZ51526630.SGD","LU0417517546.SGD","LU0787776722.HKD","LU2237443895.HKD","LU1868836757.USD","LU2468319806.SGD","LU0882574139.USD","BK4581","LU1145028129.USD","SG9999014906.USD","LU2112291526.USD","LU0079474960.USD","LU2211815571.USD","LU0225283273.USD","IE0009355771.USD","IE00B7KXQ091.USD","LU1720051108.HKD","LU2360106947.USD","LU2602419157.SGD","LU2237443978.SGD","SG9999015986.USD","IE00BFSS8Q28.SGD","LU1551013342.USD","LU2456880835.USD","LU2357305700.SGD","IE00BK4W5L77.USD","LU2746668974.SGD","LU0882574055.USD","LU2023250504.SGD","LU0006306889.USD","LU1989771016.USD","LU0238689110.USD","IE0001KFT4U8.USD","IE00B1XK9C88.USD","LU0708995401.HKD","LU2552382058.USD","LU2461242641.AUD","LU0689472784.USD","LU0133085943.USD","LU0256863902.USD","IE0004445015.USD","LU0889565916.HKD","LU0354030511.USD","LU1868836914.USD","LU2168564065.EUR","LU1868837300.USD","LU2168564222.USD","LU1983299246.USD","LU0820561818.USD","LU2023250330.USD","LU2462157665.USD","IE00BJJMRY28.SGD","LLYZ","IE00B4R5TH58.HKD","LU0256863811.USD","ELIL","LU2264538146.SGD","LU2087625088.SGD","LU1267930730.SGD","LU2491049909.HKD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0471298777.SGD","LU2237443622.USD","LU0432979614.USD","LU2236285917.USD","LU0096364046.USD","LU2756315318.SGD","LU0203201768.USD","IE00BN29S564.USD","LU2168564149.EUR","IE00B775H168.HKD","LU2063271972.USD","LU2361045086.USD","LU1061106388.HKD","BK4599","LU1093756168.USD","LU2168563687.JPY","LU0353189763.USD","LU0466842654.USD","SG9999014880.SGD","LU0820561909.HKD","LU0058720904.USD","LU0385154629.USD","LU0820562030.AUD","LU1064131342.USD","LU1623119135.USD","LU1366192091.USD","SG9999014898.SGD","LU2750360997.AUD","LU1868837136.USD","LU0823434583.USD","LU2108987350.USD","LLYX","LU0114720955.EUR","LU2756315664.SGD","LU0158827781.USD","LU2552382132.HKD","LU2089984988.USD","IE0002141913.USD","IE00B4JS1V06.HKD","LU1280957306.USD","SG9999017495.SGD","LU0320765059.SGD","SG9999015952.SGD","LU2746668461.USD","LU2491050071.SGD","IE00BKDWB100.SGD","LU1629891620.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631599351","title":"PREVIEW-Eli Lilly investors are eager for Foundayo insight after early launch data","url":"https://stock-news.laohu8.com/highlight/detail?id=2631599351","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631599351?lang=en_us&edition=fundamental","pubTime":"2026-04-29 18:00","pubTimestamp":1777456800,"startTime":"0","endTime":"0","summary":"PREVIEW-Eli Lilly investors are eager for Foundayo insight after early launch dataEarly Foundayo launch lags Novo Nordisk's WegovyInternational demand may bolster resultsPricing pressure and competiti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nL4N41A1OH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU0354030438.USD","LU2236285917.USD","LU0823416689.USD","LU2491049909.HKD","BK4007","LU1145028129.USD","LU2271345857.HKD","LU2750360641.GBP","LU1035775433.USD","LU2756315664.SGD","SGXZ51526630.SGD","LU0882574055.USD","SG9999015945.SGD","SG9999001176.USD","LU1061106388.HKD","LU1720051017.SGD","LU1868836591.USD","IE00BKPKM429.USD","SG9999013999.USD","IE00BJJMRZ35.SGD","LU1814569148.SGD","LU0238689110.USD","SG9999015952.SGD","LU1232071149.USD","LU0672654240.SGD","LU1983299246.USD","IE00BFSS7M15.SGD","LU2168564495.EUR","LU0466842654.USD","IE0005OL40V9.USD","LU2112291526.USD","SG9999018865.SGD","LU0203202063.USD","IE00BJT1NW94.SGD","LU0158827948.USD","IE0002141913.USD","LU0471298694.HKD","LU1917777945.USD","SG9999001176.SGD","LU0385154629.USD","LU2462157665.USD","LU0256863811.USD","LU2237443978.SGD","LU0058720904.USD","IE00BJJMRX11.SGD","LU0316494557.USD","IE00BK4W5M84.HKD","LU1712237335.SGD","ELIL","LU1093756168.USD","ELIS","LU0943347566.SGD","LU2063271972.USD","LU2168564149.EUR","LU2211815571.USD","LU0320765992.SGD","IE0001KFT4U8.USD","LU0006306889.USD","IE00BFSS8Q28.SGD","LLYZ","LU2360106947.USD","LU0787776722.HKD","LU2111349929.HKD","SGXZ31699556.SGD","LU0353189680.USD","IE00BJJMRY28.SGD","SGXZ57979304.SGD","LU1069344957.HKD","LU1551013342.USD","LU2089283258.USD","SGXZ99366536.SGD","LU0882574139.USD","IE00BJLML261.HKD","LU0471298777.SGD","LU2237443549.SGD","LU0097036916.USD","LU1988902786.USD","IE00B775H168.HKD","LU2602419157.SGD","IE00BN29S564.USD","LU0708995401.HKD","LU2023251221.USD","IE00BK4W5L77.USD","SGXZ81514606.USD","LU1720051108.HKD","LU2461242641.AUD","LU2471134879.HKD","LU0122379950.USD","LU0823434740.USD","LU1267930730.SGD","LU1548497426.USD","LU2168564065.EUR","LU0158827781.USD","LU0353189763.USD","LU2265009873.SGD","LU0323591593.USD","LU2106854487.HKD","LU2168564222.USD","LU1057294990.SGD","LU2087625088.SGD","LU0689472784.USD","BK4534","LU2028103732.USD","LU2237443622.USD","LU2746668974.SGD","LU0432979614.USD","SG9999014914.USD","SG9999015978.USD","LU0133085943.USD","LU2237443465.HKD","LU2168563687.JPY","LU1804176565.USD","LU2491050071.SGD","LU0964807845.USD","IE00B7KXQ091.USD","LU0456855351.SGD","LU2552382132.HKD","LU0210536198.USD","LU1629891620.HKD","BK4585","LU0354030511.USD","LU2237438978.USD","LU2023250504.SGD","LU0820562030.AUD","LU0786609619.USD","SG9999014898.SGD","LU2471134952.CNY","BK4533","IE00B2B36J28.USD","LU0061475181.USD","LU2237443895.HKD","LU1989771016.USD","LU0094547139.USD","LLYX","LU1974910355.USD","LU0256863902.USD","LU2361044865.SGD","LU2213496289.HKD","LU0109391861.USD","LU0203201768.USD","LU2756315318.SGD","LU1868837300.USD","IE00B1XK9C88.USD","IE00BKDWB100.SGD","IE00B4JS1V06.HKD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1868836914.USD","LU2089284900.SGD","LU2357305700.SGD","IE0004445015.USD","LU2417539215.USD","LU0114720955.EUR","LU1366192091.USD","BK4516","LU0640476718.USD","LU1093756325.SGD","LU0289739699.SGD","LU0198837287.USD","LU2237443382.USD","LU2750360997.AUD","LU2746668461.USD","LU1023059063.AUD","GB00BDT5M118.USD","LU0417517546.SGD","LLII","LU0266013472.USD","BK4599","LU1127390331.HKD","LU0889565916.HKD","LU1291159041.SGD","LU1323610961.USD","SG9999014906.USD","LU2324357040.USD","SG9999018857.SGD","LU2456880835.USD","BK4581","LU2896262040.SGD","LU1551013425.SGD","LU2491050154.USD","LU2264538146.SGD","LU2108987350.USD","LU2552382215.SGD","LU0096364046.USD","LU1064131342.USD","LU2552382058.USD","LU2471134796.USD","LU1868837136.USD","LU0234572021.USD","IE0004445239.USD","IE00BFTCPJ56.SGD","LU2023250330.USD","LU2471134523.USD","BK4588","LU0820561909.HKD","IE00BWXC8680.SGD","LU2089984988.USD","LU0225283273.USD","LU2361044949.HKD","SG9999014880.SGD","LU0320765059.SGD","LU2361045086.USD","LU0823434583.USD","LLY","LU1280957306.USD","SG9999015986.USD","IE0009355771.USD","LU0079474960.USD","LU0683600562.USD","LU1868836757.USD","SG9999017495.SGD","LU0820561818.USD","LU0109394709.USD","LU1623119135.USD","IE00B1BXHZ80.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631593678","title":"Update: Amgen's Tavneos Proposed to be Withdrawn by US FDA's Center for Drug Evaluation and Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2631593678","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631593678?lang=en_us&edition=fundamental","pubTime":"2026-04-29 17:17","pubTimestamp":1777454243,"startTime":"0","endTime":"0","summary":"(Updates with Amgen's response in the sixth and seventh paragraphs.)Amgen's (AMGN) Tavneos has been proposed to be withdrawn by the US Food and Drug Administration's Center for Drug Evaluation and Res","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LABU","BK4534","SG9999001440.SGD","LU0289739699.SGD","IE00B2B36J28.USD","LU2242652126.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU2242646821.SGD","AMGN","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","LU1061106388.HKD","BK4139","BK4588","BK4533","BK4566","BK4581","LU0889565916.HKD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU2468319806.SGD","LU0122379950.USD","LU1057294990.SGD","BK4585","LU0868494617.USD","LU1571399168.USD","LU1983299246.USD","LU2089984988.USD","IE0002141913.USD","LU0058720904.USD","LU0320765992.SGD","IE0009355771.USD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631552912","title":"Pfizer : Jefferies Raises Target Price to $35 From $34","url":"https://stock-news.laohu8.com/highlight/detail?id=2631552912","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631552912?lang=en_us&edition=fundamental","pubTime":"2026-04-29 11:48","pubTimestamp":1777434521,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41B0WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1023059063.AUD","BK4007","BK4592","LU0225771236.USD","BK4550","LU1066051498.USD","BK4533","BK4588","BK4581","PFE","LU0058720904.USD","BK4568","IE00BBT3K403.USD","LU0225284248.USD","SG9999002224.SGD","LU0234572021.USD","LU0868494617.USD","LU0122379950.USD","SG9999013999.USD","IE0002270589.USD","LU1894683264.USD","LU0306807586.USD","BK4585","LU1894683348.USD","BK4534","LU0306806265.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU0321505439.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU1883839398.USD","SG9999003800.SGD","SG9999001176.SGD","BK4599","LU1057294990.SGD","LU0985481810.HKD","LU0321505868.SGD","LU0170899867.USD","LU0456855351.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","SG9999002232.USD","SG9999001176.USD","LU0289739699.SGD","LU1066053197.SGD","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631534194","title":"Health Canada approves first generic version of Novo Nordisk’s Ozempic","url":"https://stock-news.laohu8.com/highlight/detail?id=2631534194","media":"Bloomberg","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631534194?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:46","pubTimestamp":1777412760,"startTime":"0","endTime":"0","summary":"Health Canada has approved the first generic version of Danish drugmaker Novo Nordisk’s NOVOb.CO blockbuster diabetes drug Ozempic made by Indian drugmaker Dr Reddy’s Laboratories REDY.NS, its website showed on Tuesday.","market":"sg","thumbnail":"https://www.bnnbloomberg.ca/resizer/v2/BRRVWOGA5MHRNACL7N675W4HKA.jpg?smart=true&auth=51159eb2a05cafde3dea702464b51b43d6113bdd9cbb026f15ac0559a7cf8794&width=800&height=450","type":0,"news_type":0,"thumbnails":["https://www.bnnbloomberg.ca/resizer/v2/BRRVWOGA5MHRNACL7N675W4HKA.jpg?smart=true&auth=51159eb2a05cafde3dea702464b51b43d6113bdd9cbb026f15ac0559a7cf8794&width=800&height=450"],"rights":{"source":"bnn_bloomberg_highlight","url":"https://www.bnnbloomberg.ca/business/company-news/2026/04/28/health-canada-approves-first-generic-version-of-novo-nordisks-ozempic/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bnnbloomberg.ca/business/company-news/2026/04/28/health-canada-approves-first-generic-version-of-novo-nordisks-ozempic/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"bnn_bloomberg_highlight","symbols":["IE00BKVL7J92.USD","NVOX","LU1093756168.USD","BK4532","LU0154236417.USD","LU1093756325.SGD","BK4585","NVO","NVOH","BK4599","BK4588","IE00BZ1G4Q59.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631533534","title":"Novo Nordisk’s Oral Ozempic And Pediatric Plans Reframe GLP-1 Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2631533534","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631533534?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:05","pubTimestamp":1777410327,"startTime":"0","endTime":"0","summary":"Novo Nordisk (NYSE:NVO) has received FDA approval for an oral version of Ozempic for adults with type 2 diabetes.\nThe company also reported positive results from pediatric trials and plans to seek a label expansion to include children.\nThese product updates come as interest in GLP-1 treatments continues to grow across different patient groups.\n\nNovo Nordisk, trading at $41.2, has seen mixed share price performance, with a 14.3% gain over the past 30 days but a 21.4% decline year to date and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisks-oral-ozempic-and-pediatric-plans-reframe-glp-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-nvo/novo-nordisk/news/novo-nordisks-oral-ozempic-and-pediatric-plans-reframe-glp-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NVOX","LU1093756168.USD","NVO","BK4144","BK4007","BK4585","BK4532","BK4599","NVOH","BK4588","LU1093756325.SGD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631053949","title":"Biogen Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2631053949","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631053949?lang=en_us&edition=fundamental","pubTime":"2026-04-29 05:01","pubTimestamp":1777410060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  rose 1.50% to $183.38 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.49% to 7,138.80 and Dow Jones Industrial Average  falling 0.05% to 49,141.93.The stock's rise snapped a three-day losing streak.Biogen Inc. closed 9.40% below its 52-week high of $202.41, which the company achieved on February 6th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 1.09% to $227.79, Pfizer Inc.  fell 1.16% to $26.48, and AbbVie Inc.  rose 0.16% to $197.69.Trading volume  eclipsed its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled April 28, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345769631.USD","LU0882574055.USD","LU2133065610.SGD","LU0708994859.HKD","LU2129689431.USD","SG9999001440.SGD","LU1551013342.USD","SG9999003800.SGD","LU0345769128.USD","LU1057294990.SGD","LU2430703095.HKD","IE000MB6IJN5.SGD","LU0210536198.USD","LU1043141123.HKD","LU0128525929.USD","LU0211327993.USD","LU0289739699.SGD","LU0124676726.USD","LU1061106388.HKD","LU1244550221.USD","LU0787776722.HKD","LU0345770308.USD","IE00BN8TJ469.HKD","LU1037948897.HKD","LU2237443895.HKD","LU1059921491.USD","SG9999015986.USD","LU1244550494.USD","IE00B3T34201.USD","LU0053666078.USD","LU0640476718.USD","LU0289961442.SGD","LU0198837287.USD","LU0098860793.USD","LU0306806265.USD","LU1989772840.SGD","LU2750360641.GBP","LU2487616109.SGD","IE000BZT7R73.USD","LU1003077747.HKD","LU2430703178.SGD","IE00BDGV0183.EUR","LU0321505439.SGD","LU0965509010.AUD","LU0203345920.USD","IE000F7OJYX1.SGD","LU0683600562.USD","IE00B1BXHZ80.USD","LU2237443622.USD","LU1430594728.SGD","LU0306807586.USD","BK4581","LU1066053197.SGD","IE00BBT3K403.USD","LU1093756168.USD","LU1162221912.USD","LU0158827948.USD","IE0034235303.USD","LU2602419157.SGD","LU0426412945.USD","LU0985481810.HKD","LU1196500208.SGD","SG9999002224.SGD","LU1121112475.USD","LU1267930490.SGD","LU1261432733.SGD","SG9999011175.SGD","LU0795875086.SGD","IE00B4R5TH58.HKD","LU0225771236.USD","IE00BKVL7J92.USD","LU0456855351.SGD","LU0310799852.SGD","IE000WAW04H5.SGD","LU0861579265.USD","BK4007","LU0738911758.USD","BK4585","LU2237443549.SGD","LU2129689605.HKD","LU0029864427.USD","BIIB","LU0069063385.USD","LU1883839398.USD","IE000M9KFDE8.USD","LU2089283258.USD","LU0553294199.USD","IE0004445239.USD","IE00BVYPNW00.USD","LU0225284248.USD","IE00BGHQF631.EUR","LU1935042991.SGD","LU2237443978.SGD","LU0417517546.SGD","LU1145028129.USD","LU1032466523.USD","LU0122379950.USD","LU2023250330.USD","LU2237443465.HKD","IE00BSNM7G36.USD","LU2471134523.USD","SG9999015945.SGD","LU0234572021.USD","LU2756315664.SGD","IE00B42XCP33.USD","SG9999015978.USD","LU0203347892.USD","IE00BJJMRZ35.SGD","BK4568","LU0965508806.USD","LU0058720904.USD","LU1037948541.HKD","BK4532","LU2112291526.USD","LU0823416689.USD","LU1496350171.SGD","IE00BJT1NW94.SGD","BK4550","LU0210528500.USD","LU0170899867.USD","LU2089984988.USD","LU1585245621.USD","LU0965509101.SGD","IE0002141913.USD","LU0859254822.USD","LU1023059063.AUD","LU2505996681.GBP","IE00B7SZLL34.SGD","IE00BLSP4239.USD","LU0310800379.SGD","LU0070217475.USD","IE00B3PB1722.GBP","LU1066051811.HKD","LU0964807845.USD","LU0545039389.USD","LU1989772923.USD","LU1280957306.USD","LU1718418525.SGD","LU0511384066.AUD","LU1032955483.USD","LU2087621335.USD","IE0000B7K699.USD","IE00BFXG1179.USD","LU2750360997.AUD","IE00B19Z3581.USD","LU1629891620.HKD","LU1674673691.USD","LU0795875169.SGD","LU1043141396.HKD","LU0345770993.USD","IE00BLSP4452.SGD","SG9999001176.SGD","LU1221951129.SGD","IE0009355771.USD","LU0466842654.USD","LU1066051498.USD","LU1914381329.SGD","LU0912757837.SGD","IE00BZ1G4Q59.USD","LU1839511570.USD","LU0820562030.AUD","LU1674673428.USD","LU1267930813.SGD","LU2357627491.SGD","LU1732799900.SGD","LU1934455863.HKD","LU1066051225.USD","IE00B2B36J28.USD","LU0792757196.USD","LU2471134952.CNY","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0994945656.USD","LU0689626769.HKD","IE00B19Z9P08.USD","BK4588","LU0965509283.SGD","LU0661504455.SGD","BK4566","LU0689472784.USD","LU0256863811.USD","LU2129689514.USD","LU0472753341.HKD","LU1291159041.SGD","LU1934455194.USD","BK4533","LU2237443382.USD","LU0432979614.USD","LU1551013425.SGD","LU2471134879.HKD","LU2430703251.USD","IE00B894F039.SGD","LU2347655156.SGD","LU1934455277.USD","IE00BFTCPJ56.SGD","IE0001KFT4U8.USD","LU2089284900.SGD","IE00B19Z9Z06.USD","LU0321505868.SGD","BK4504","LU2471134796.USD","BK4559","LU2468319806.SGD","IE0002270589.USD","LU0234570918.USD","SG9999001176.USD","LU0426417589.USD","LU0256863902.USD","LU1989771016.USD","LU0109394709.USD","LU1894683264.USD","LU2896262040.SGD","SG9999015952.SGD","LU0889566641.SGD","LU0114720955.EUR","BK4534","BK4599","LU0057025933.USD","LU1732800096.USD","LU1894683348.USD","LU1506573853.SGD","SG9999013999.USD","LU2023251221.USD","LU0868494708.USD","LU0985320562.USD","LU0820561909.HKD","LU0320765646.SGD","LU0320765992.SGD","BK4139","LU1983299246.USD","IE00BVYPNV92.GBP","LU0868494617.USD","LU0943347566.SGD","LU1093756325.SGD","LU2592432038.USD","LU1267930573.SGD","LU2505996509.AUD","LU1244550577.SGD","LU1221951046.USD","LU0889565916.HKD","LU0820561818.USD","LU2213496289.HKD","LU1496350502.SGD","LU0211328371.USD","IE000SO60NU8.SGD","LU1074936037.SGD","SG9999002232.USD","LU2756315318.SGD","LU0289739343.SGD","LU1929549753.HKD","LU0949170772.SGD","LU0942090050.USD","BK4592","LU1778281490.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":1,"totalSize":350,"code":"91000000","status":"200"}]}}